News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Curis, Inc. Reports First Quarter 2004 Results
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Curis, Inc. (Nasdaq:CRIS - News), a therapeutic drug development company, today reported its financial results for the first quarter ended March 31, 2004.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Curis, Inc.
MORE ON THIS TOPIC
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
March 12, 2026
·
1 min read
·
Annalee Armstrong
Layoff Tracker
Vistagen, Evotec, Reckitt Benckiser Downsize, Collectively Affecting Hundreds
March 12, 2026
·
35 min read
·
BioSpace Editorial Staff
Weight loss
Lilly Flags ‘Concerning’ Impurities in Compounded Tirzepatide
March 12, 2026
·
2 min read
·
Tristan Manalac
C-suite
J&J, AbbVie CEOs See Pay Spike to More Than $30M
March 12, 2026
·
1 min read
·
Tristan Manalac
